Xiufen Chen

机构：Fujian Medical University, University of Chicago, Putian University · ORCID：0009-0006-6895-2819

发表论文 131 篇 · 总被引 2417 次 · h-index 24

代表论文

• Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity (2023 · Nature · 被引 142)
• Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities (2024 · JAMA Internal Medicine · 被引 34)
• Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody response (2025 · Blood · 被引 26)
• TIGIT is a key inhibitory checkpoint receptor in lymphoma (2023 · Journal for ImmunoTherapy of Cancer · 被引 16)
• Histopathologic Grading of Residual Tumor Predicts Survival of Intrahepatic Cholangiocarcinoma Patients Treated With Neoadjuvant Therapy (2025 · The American Journal of Surgical Pathology · 被引 12)
• T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses (2024 · Cancer Immunology Research · 被引 10)